Skip to content

Zymeworks ZYME Accrued Income Taxes, Current

Accrued Income Taxes, Current at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
$0-100%
Charles River Laboratories logo
Charles River LaboratoriesCRL
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's accrued income taxes, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's accrued income taxes, current?
Zymeworks (ZYME) reported accrued income taxes, current of $66K in Q1 2026.
How has Zymeworks's accrued income taxes, current changed year-over-year?
Zymeworks's accrued income taxes, current decreased by 48.0% year-over-year, from $127K to $66K.
What does accrued income taxes, current mean?
This represents the estimated amount of income tax payable to government authorities for the current period. It reflects the company's tax liability based on taxable income generated during the year, which is due within the next twelve months. It is a key indicator of the company's immediate tax obligations.